Content about Insulin therapy

November 9, 2012

FDA panel recommends approval for two Novo Nordisk insulin products

A Food and Drug Administration panel has voted to support two experimental insulin treatments made by Novo Nordisk, the Danish drug maker said Thursday.

June 12, 2012

Global study reveals correlation between insulin dosing irregularities, hypoglycemia

One-quarter of Type 2 diabetes patients do not take basal insulin as prescribed, while more than one-third suffer from hypoglycemia, according to a global survey funded by Novo Nordisk.

June 11, 2012

Study: Insulin degludec reduces risk of nocturnal hypoglycemia among Type 2 diabetes patients

An investigational insulin being developed by Novo Nordisk significantly reduced the rate of hypoglycemia at night in adults with Type 2 diabetes, according to results of a late-stage clinical trial presented at the 72nd Scientific Sessions of the American Diabetes Association.

May 22, 2012

Novo Nordisk's Levemir approved for children ages 2 to 5 years

The Food and Drug Administration has approved a treatment for Type 1 diabetes in children ages 2 to 5 years.

April 9, 2012

FDA approves labeling change for Novo Nordisk diabetes drug

The Food and Drug Administration has approved a change to the label of a Novo Nordisk drug stating that it offers superior blood-sugar control to a competing drug made by Merck, based on results of two clinical studies, Novo Nordisk said Monday.

February 1, 2012

Study: In Type 2 diabetics not on insulin, self-monitoring has no impact on disease

Self-monitoring blood glucose levels in Type 2 diabetics not on an insulin regimen may contribute little to managing the disease, according to an analysis published online last month by The Cochran Library.

December 1, 2011

Lilly study to determine why many diabetes patients don't reach blood-glucose goals

Many people with Type 2 diabetes have managed to integrate the treatments they must take into their daily lives, but many do not reach their blood-glucose goals after they start insulin therapy.

November 16, 2011

FDA approves Tandem insulin pump

The Food and Drug Administration has approved a new insulin-delivery system for Type 1 diabetes made by Tandem Diabetes Care, the company said Wednesday.

September 16, 2011

BMS, AstraZeneca drug added to insulin reduces blood sugar more than placebo

A diabetes drug made by Bristol-Myers Squibb and AstraZeneca significantly reduced Type 2 diabetes patients' blood-sugar levels, compared with placebo, when added to insulin, according to results of a new study.

September 13, 2011

Study: Sanofi insulin reduces weight gain, increases blood sugar control

An insulin analogue made by Sanofi appears to work better in certain cases than competing treatments at reducing weight gain and controlling blood sugar among patients with Type 2 diabetes.

July 6, 2011

MannKind: Patients have better view of insulin therapy when using Afrezza

Patients with Type 1 diabetes using an insulin product made by MannKind expressed a better opinion about insulin therapy than those taking the standard treatment, according to a study presented at the American Diabetes Association’s 71st Scientific Sessions.

June 27, 2011

Novo Nordisk's Victoza helps patients achieve blood-sugar control when switching from exenatide or sitagliptin

Novo Nordisk unveiled data from two extension studies at the 71st annual Scientific Sessions of the American Diabetes Association in San Diego that show its diabetes drug, when combined with other medications, may help patients achieve blood-sugar control.

June 17, 2011

Liraglutide may prompt optimal blood-glucose levels in Type 1 diabetics

A popular Type 2 diabetes treatment may help Type 1 diabetics achieve control of their blood-glucose levels, according to a small, observational study conducted at the University of Buffalo.

June 9, 2011

FDA approves labeling change for Eli Lilly insulin product

Patients with Type 1 diabetes using an insulin product made by Eli Lilly can store it in their pumps for longer periods of time, while children using it have additional options, thanks to a labeling change approved Wednesday by the Food and Drug Administration.

May 13, 2011

Study finds link between insomnia, high insulin resistance among diabetics

Diabetics that have trouble sleeping likely experience high insulin resistance and have a more difficult time controlling the disease, according to study findings published in the June issue of Diabetes Care.

March 28, 2011

Study: Counting carbs can improve quality of life in Type 1 diabetes patients on insulin pump therapy

A study published online in the journal Diabetes Care, and slated for the April print issue, suggested that counting carbohydrates could lead to an improvement in quality of life and a reduction in body mass index and waist circumference in patients with Type 1 diabetes who receive continuous subcutaneous insulin infusions.

March 14, 2011

Biodel discloses accelerated development plan for diabetes drugs

A drug maker focused on development and commercialization of diabetes treatments unveiled its accelerating clinical development plans of two drug candidates.

December 13, 2010

Recreating islet cells can boost insulin production, study finds

In patients with Type 1 diabetes, the islet cells of the pancreas are destroyed, thus eliminating the organ’s ability to produce insulin.

November 2, 2010

Biodel receives complete response letter for Linjeta

The Food and Drug Administration has turned down an application for an insulin product made...

November 2, 2010

Lilly CEO: 'New approaches' must be found to combat diabetes

The CEO of drug maker Eli Lilly has called for a “wave of invention” to...

September 14, 2010

Oramed calls oral insulin drug trial 'successful'

Oramed Pharmaceuticals has seen promising results from a clinical trial of an oral insulin for...